Each mL contains 1 mg of pemirolast potassium.
It also contains concentrated glycerin, dibasic sodium phosphate hydrate, sodium dihydrogen phosphate dihydrate, and benzalkonium chloride as additives.
Pemirolast potassium is an antiallergic agent possessing a strong inhibitory effect on release of chemical mediators. Clinically, its usefulness has been demonstrated against allergic conjunctivitis and vernal conjunctivitis by twice daily instillation.
Allergic conjunctivitis, vernal conjunctivitis.
Instill one drop in each eye twice a day (morning and evening).
Since the safety of this drug during pregnancy has not been established, this drug should not be given to pregnant women or women suspected of being pregnant, unless the potential benefits outweigh the possible hazards. Likewise, pemirolast has not been tested in lactating mothers.
Safety of this drug in prematures, newborns, and infants has not been established (no clinical experience).
Since the safety of this drug during pregnancy has not been established, this drug should not be given to pregnant women or women suspected of being pregnant, unless the potential benefits outweigh the possible hazards. Likewise, pemirolast has not been tested in lactating mothers.
If the following adverse reactions are observed, appropriate measures such as discontinuing administration should be taken. (See table.)
Click on icon to see table/diagram/image
In case that this product contacts the palpebral skin, etc. when instilled, it should be wiped off immediately.
The tip of the eyedropper must not come into contact with the eyes at the time of application.
Store at temperatures not exceeding 30°C.
Keep bottle tightly closed when not in use.
Discard contents 1 month after opening.
S01GX - Other antiallergics ; Used as ophthalmologic antiallergics.
Alegysal ophth soln 0.1%
5 mL x 1's (P240/bottle)
Sign Out
Click on icon to see table/diagram/image
Continue with Google
Sign up with email
Already a member?
Sign in
